SI0980251T1 - Tissue factor for influencing blood vessel formation - Google Patents

Tissue factor for influencing blood vessel formation

Info

Publication number
SI0980251T1
SI0980251T1 SI9830279T SI9830279T SI0980251T1 SI 0980251 T1 SI0980251 T1 SI 0980251T1 SI 9830279 T SI9830279 T SI 9830279T SI 9830279 T SI9830279 T SI 9830279T SI 0980251 T1 SI0980251 T1 SI 0980251T1
Authority
SI
Slovenia
Prior art keywords
tissue factor
blood vessel
vessel formation
influencing blood
influencing
Prior art date
Application number
SI9830279T
Other languages
Slovenian (sl)
Inventor
Peter Nawroth
Katsumi Nakagawa
Youming Zhang
Original Assignee
Merckle Gmbh
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merckle Gmbh filed Critical Merckle Gmbh
Publication of SI0980251T1 publication Critical patent/SI0980251T1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/36—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against blood coagulation factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/36—Blood coagulation or fibrinolysis factors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Immunology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Dermatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Vascular Medicine (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Epidemiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Materials For Medical Uses (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Instructional Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)

Abstract

The invention relates to the use of tissue factor for influencing, in particular activating, the formation of blood vessels, above all for wound healing.
SI9830279T 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation SI0980251T1 (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE19719652A DE19719652A1 (en) 1997-05-09 1997-05-09 Use of tissue factor
DEPCT/DE98/01278 1998-05-07
PCT/DE1998/001306 WO1998051321A1 (en) 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation
EP98933500A EP0980251B1 (en) 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation

Publications (1)

Publication Number Publication Date
SI0980251T1 true SI0980251T1 (en) 2003-02-28

Family

ID=7829124

Family Applications (1)

Application Number Title Priority Date Filing Date
SI9830279T SI0980251T1 (en) 1997-05-09 1998-05-08 Tissue factor for influencing blood vessel formation

Country Status (16)

Country Link
EP (1) EP0980251B1 (en)
JP (1) JP2001527555A (en)
AT (1) ATE222501T1 (en)
AU (1) AU746782B2 (en)
CA (1) CA2288117A1 (en)
CZ (1) CZ293005B6 (en)
DE (2) DE19719652A1 (en)
DK (1) DK0980251T3 (en)
ES (1) ES2184299T3 (en)
HU (1) HUP0003831A3 (en)
IS (1) IS5231A (en)
NO (1) NO995459D0 (en)
PL (1) PL336662A1 (en)
PT (1) PT980251E (en)
SI (1) SI0980251T1 (en)
WO (1) WO1998051321A1 (en)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030109680A1 (en) 2001-11-21 2003-06-12 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
US7749498B2 (en) 1997-03-10 2010-07-06 Genentech, Inc. Antibodies for inhibiting blood coagulation and methods of use thereof
US20060235209A9 (en) 1997-03-10 2006-10-19 Jin-An Jiao Use of anti-tissue factor antibodies for treating thromboses
US5986065A (en) 1997-03-10 1999-11-16 Sunol Molecular Corporation Antibodies for inhibiting blood coagulation and methods of use thereof
DE19719652A1 (en) * 1997-05-09 1998-12-03 Merckle Gmbh Use of tissue factor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5770209A (en) * 1991-08-30 1998-06-23 University Of South Florida Acceleration of wound healing using connective tissue growth factor
WO1994005328A1 (en) * 1992-08-28 1994-03-17 The Scripps Research Institute Inhibition of tumor metastasis via neutralization of tissue factor function
FR2696095B1 (en) * 1992-09-30 1994-11-25 Inoteb Biological glue based on proteins coagulable by thrombin, enriched in platelet factors, its preparation and its application.
PT804562E (en) * 1994-07-12 2003-02-28 Human Genome Sciences Inc CONJUNCTIVE TISSUE GROWING FACTOR 2
US5981471A (en) * 1997-02-06 1999-11-09 Entremed, Inc. Compositions and methods for inhibiting cellular proliferation
DE19719652A1 (en) * 1997-05-09 1998-12-03 Merckle Gmbh Use of tissue factor

Also Published As

Publication number Publication date
NO995459L (en) 1999-11-08
EP0980251A1 (en) 2000-02-23
AU8331598A (en) 1998-12-08
PT980251E (en) 2003-01-31
EP0980251B1 (en) 2002-08-21
CZ293005B6 (en) 2004-01-14
AU746782B2 (en) 2002-05-02
ATE222501T1 (en) 2002-09-15
PL336662A1 (en) 2000-07-03
CZ391299A3 (en) 2000-04-12
HUP0003831A3 (en) 2003-08-28
JP2001527555A (en) 2001-12-25
DE19719652A1 (en) 1998-12-03
IS5231A (en) 1999-10-26
CA2288117A1 (en) 1998-11-19
ES2184299T3 (en) 2003-04-01
DE59805246D1 (en) 2002-09-26
WO1998051321A9 (en) 1999-04-01
NO995459D0 (en) 1999-11-08
WO1998051321A1 (en) 1998-11-19
HUP0003831A2 (en) 2001-02-28
DK0980251T3 (en) 2002-11-18

Similar Documents

Publication Publication Date Title
HK1047404A1 (en) Vascular coating composition
AU1268297A (en) Artificial blood vessel
AU8337898A (en) Implantable valve for blood vessels
CA2340320A1 (en) Use of an angiogenic factor for the treatment of microascular angiopathies
NO971341D0 (en) Promoter for receptor tyrosine kinase TIE
AU1873599A (en) Stent for implantation in the human body, especially in blood vessels
EP0861082A4 (en) Therapy for tissue membrane insufficiency
EP0651655A4 (en) Blockade of protein c activation reduces microvascular surgical blood loss.
MX9700244A (en) A polyholoside utilization in a cleaning or de-making up composition, and composition including it.
SI0980251T1 (en) Tissue factor for influencing blood vessel formation
AU4545597A (en) Biomembrane suitable for use in substitution, reconstruction, induction of angiogenesis, neoformation or regeneration of human or animal organs or tissues
AU2001232053A1 (en) System for the extracorporeal treatment of blood
IL131478A0 (en) Methods for treatment of scar tissue
EP1417971A3 (en) Use of an angiogenic factor for the treatment of microvascular angiopathies
WO1998024482A3 (en) Use of endothelin conjugates in therapy, new endothelin conjugates, substances containing them, and processes for producing them
ZA981558B (en) Inclusion complexes in aqueous solution
ZA973442B (en) Component B as cicatrizant.
AU5448490A (en) Compositions and processes for improving the cosmetic appearance, growths or healing characteristics of tissue
UA32315A (en) Technique for skin suturing
GB9812278D0 (en) Use of a wound dressing in the treatment of acute wounds
DE69832075D1 (en) USE OF EPROSARTAN FOR THE TREATMENT OF ISOLATED SYSTOLIC BLOOD HIGH PRESSURE
ATE94759T1 (en) USE OF DEXTRANSULFATE, OPTIONALLY IN COMBINATION WITH ANTI-ANDROGENIC AGENTS FOR THE TREATMENT OF HUMAN PROTATE CANCER.
CA2200846A1 (en) Promoter for the receptor tyrosine kinase, tie
UA32241A (en) Method for treating inflammations in experiment
UA31631A (en) Device for attaching endoprosthesis to blood vessel